3/24
05:31 pm
legn
CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight
Medium
Report
CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight
3/24
05:31 pm
legn
CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight
Medium
Report
CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight
3/18
05:31 pm
legn
Multiple Myeloma Market to Witness Substantial Growth -- Key Trends and Forecasts of Different Reports for the Next Decade | DelveInsight
Low
Report
Multiple Myeloma Market to Witness Substantial Growth -- Key Trends and Forecasts of Different Reports for the Next Decade | DelveInsight
3/18
05:31 pm
legn
Multiple Myeloma Market to Witness Substantial Growth -- Key Trends and Forecasts of Different Reports for the Next Decade | DelveInsight
Low
Report
Multiple Myeloma Market to Witness Substantial Growth -- Key Trends and Forecasts of Different Reports for the Next Decade | DelveInsight
3/17
12:56 pm
legn
Legend Biotech Co. (NASDAQ: LEGN) had its price target lowered by analysts at Morgan Stanley from $82.00 to $80.00. They now have an "overweight" rating on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) had its price target lowered by analysts at Morgan Stanley from $82.00 to $80.00. They now have an "overweight" rating on the stock.
3/12
10:12 am
legn
Legend Biotech Co. (NASDAQ: LEGN) had its "neutral" rating re-affirmed by analysts at Guggenheim.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) had its "neutral" rating re-affirmed by analysts at Guggenheim.
3/12
08:15 am
legn
Legend Biotech Co. (NASDAQ: LEGN) had its price target raised by analysts at HC Wainwright from $73.00 to $75.00. They now have a "buy" rating on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) had its price target raised by analysts at HC Wainwright from $73.00 to $75.00. They now have a "buy" rating on the stock.
3/12
02:40 am
legn
GenScript Biotech Corporation Reports FY 2024 Results
Medium
Report
GenScript Biotech Corporation Reports FY 2024 Results
3/11
08:25 am
legn
Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights [Yahoo! Finance]
Medium
Report
Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights [Yahoo! Finance]
3/11
07:00 am
legn
Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights
Medium
Report
Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights
3/4
08:00 am
legn
New LLS Docuseries on CAR T-cell Advances Aims to Educate and Empower Blood Cancer Patients
Low
Report
New LLS Docuseries on CAR T-cell Advances Aims to Educate and Empower Blood Cancer Patients
2/25
09:34 am
legn
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results [Yahoo! Finance]
Low
Report
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results [Yahoo! Finance]
2/25
08:00 am
legn
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results
Low
Report
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results
2/23
01:39 pm
legn
Why Legend Biotech Corporation (LEGN) is the Most Oversold Pharma Stock to Buy According to Analysts [Yahoo! Finance]
Medium
Report
Why Legend Biotech Corporation (LEGN) is the Most Oversold Pharma Stock to Buy According to Analysts [Yahoo! Finance]
2/13
02:18 pm
legn
Is Legend Biotech (LEGN) the Best Mid-Cap Growth Stock to Buy According to Analysts? [Yahoo! Finance]
Low
Report
Is Legend Biotech (LEGN) the Best Mid-Cap Growth Stock to Buy According to Analysts? [Yahoo! Finance]
1/21
08:02 am
legn
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $73.00 price target on the stock.
Medium
Report
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $73.00 price target on the stock.
1/17
01:28 pm
legn
Legend Biotech Corporation (LEGN): The Biotech Stock with Biggest Upside Potential [Yahoo! Finance]
Low
Report
Legend Biotech Corporation (LEGN): The Biotech Stock with Biggest Upside Potential [Yahoo! Finance]